skip to main content
Guest
My Research
My Account
Sign out
Sign in
This feature requires javascript
Library Search
Find Databases
Browse Search
E-Journals A-Z
E-Books A-Z
Citation Linker
Help
Language:
English
Vietnamese
This feature required javascript
This feature requires javascript
Primo Search
All Library Resources
All
Course Materials
Course Materials
Search For:
Clear Search Box
Search in:
All Library Resources
Or hit Enter to replace search target
Or select another collection:
Search in:
All Library Resources
Search in:
Print Resources
Search in:
Digital Resources
Search in:
Online E-Resources
Advanced Search
Browse Search
This feature requires javascript
Search Limited to:
Search Limited to:
Resource type
criteria input
All items
Books
Articles
Images
Audio Visual
Maps
Graduate theses
Show Results with:
criteria input
that contain my query words
with my exact phrase
starts with
Show Results with:
Search type Index
criteria input
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
Show Results with:
in the title
Show Results with:
anywhere in the record
in the title
as author/creator
in subject
Full Text
ISBN
ISSN
TOC
Keyword
Field
This feature requires javascript
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia
Nature (London), 2021-06, Vol.594 (7861), p.88-93
[Peer Reviewed Journal]
Copyright Nature Publishing Group Jun 3, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03491-6 ;PMID: 33827113
Full text available
Citations
Cited by
View Online
Details
Recommendations
Reviews
Times Cited
External Links
This feature requires javascript
Actions
Add to My Research
Remove from My Research
E-mail
Print
Permalink
Citation
EasyBib
EndNote
RefWorks
Delicious
Export RIS
Export BibTeX
This feature requires javascript
Title:
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia
Author:
Braga, Luca
;
Ali, Hashim
;
Secco, Ilaria
;
Chiavacci, Elena
;
Neves, Guilherme
;
Goldhill, Daniel
;
Penn, Rebecca
;
Jimenez-Guardeño, Jose M
;
Ortega-Prieto, Ana M
;
Bussani, Rossana
;
Cannatà, Antonio
;
Rizzari, Giorgia
;
Collesi, Chiara
;
Schneider, Edoardo
;
Arosio, Daniele
;
Shah, Ajay M
;
Barclay, Wendy S
;
Malim, Michael H
;
Burrone, Juan
;
Giacca, Mauro
Subjects:
Aged
;
Aged, 80 and over
;
Alveolar Epithelial Cells - drug effects
;
Alveolar Epithelial Cells - pathology
;
Alveolar Epithelial Cells - virology
;
Alveoli
;
Animals
;
Anoctamins - antagonists & inhibitors
;
Anoctamins - metabolism
;
Anthelmintic agents
;
Calcium
;
Calcium conductance
;
Calcium Signaling - drug effects
;
Calcium signalling
;
Cell Fusion
;
Cell Line
;
Cell surface
;
Chloride Channels - metabolism
;
Chlorocebus aethiops
;
Coronaviruses
;
COVID-19
;
COVID-19 - metabolism
;
COVID-19 - pathology
;
COVID-19 - virology
;
Drug dosages
;
Drug Evaluation, Preclinical
;
Drugs
;
Female
;
Giant Cells - drug effects
;
Giant Cells - metabolism
;
Giant Cells - virology
;
Humans
;
Inflammation
;
Ion channels
;
Lung - drug effects
;
Lung - pathology
;
Lung - virology
;
Lungs
;
Male
;
Membrane conductance
;
Membranes
;
Middle East respiratory syndrome
;
Morphology
;
Niclosamide
;
Oscillations
;
Pathogenesis
;
Phosphatidylserine
;
Plasma
;
Pneumocytes
;
Proteins
;
Respiratory function
;
SARS-CoV-2 - drug effects
;
SARS-CoV-2 - metabolism
;
SARS-CoV-2 - pathogenicity
;
Severe acute respiratory syndrome
;
Severe acute respiratory syndrome coronavirus 2
;
Spike Glycoprotein, Coronavirus - antagonists & inhibitors
;
Spike Glycoprotein, Coronavirus - metabolism
;
Spike protein
;
Substrates
;
Syncytia
;
Viral diseases
;
Virus Replication - drug effects
;
Viruses
Is Part Of:
Nature (London), 2021-06, Vol.594 (7861), p.88-93
Description:
COVID-19 is a disease with unique characteristics that include lung thrombosis , frequent diarrhoea , abnormal activation of the inflammatory response and rapid deterioration of lung function consistent with alveolar oedema . The pathological substrate for these findings remains unknown. Here we show that the lungs of patients with COVID-19 contain infected pneumocytes with abnormal morphology and frequent multinucleation. The generation of these syncytia results from activation of the SARS-CoV-2 spike protein at the cell plasma membrane level. On the basis of these observations, we performed two high-content microscopy-based screenings with more than 3,000 approved drugs to search for inhibitors of spike-driven syncytia. We converged on the identification of 83 drugs that inhibited spike-mediated cell fusion, several of which belonged to defined pharmacological classes. We focused our attention on effective drugs that also protected against virus replication and associated cytopathicity. One of the most effective molecules was the antihelminthic drug niclosamide, which markedly blunted calcium oscillations and membrane conductance in spike-expressing cells by suppressing the activity of TMEM16F (also known as anoctamin 6), a calcium-activated ion channel and scramblase that is responsible for exposure of phosphatidylserine on the cell surface. These findings suggest a potential mechanism for COVID-19 disease pathogenesis and support the repurposing of niclosamide for therapy.
Publisher:
England: Nature Publishing Group
Language:
English
Identifier:
ISSN: 0028-0836
EISSN: 1476-4687
DOI: 10.1038/s41586-021-03491-6
PMID: 33827113
Source:
ProQuest One Psychology
MEDLINE
ProQuest Central
This feature requires javascript
This feature requires javascript
Back to results list
This feature requires javascript
This feature requires javascript
Searching Remote Databases, Please Wait
Searching for
in
scope:(TDTS),scope:(SFX),scope:(TDT),scope:(SEN),primo_central_multiple_fe
Show me what you have so far
This feature requires javascript
This feature requires javascript